Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Veracyte (VCYT) FCF Margin (2016 - 2025)

Historic FCF Margin for Veracyte (VCYT) over the last 14 years, with Q3 2025 value amounting to 31.82%.

  • Veracyte's FCF Margin rose 79000.0% to 31.82% in Q3 2025 from the same period last year, while for Sep 2025 it was 19.83%, marking a year-over-year increase of 65600.0%. This contributed to the annual value of 14.31% for FY2024, which is 48300.0% up from last year.
  • According to the latest figures from Q3 2025, Veracyte's FCF Margin is 31.82%, which was up 79000.0% from 24.83% recorded in Q2 2025.
  • Over the past 5 years, Veracyte's FCF Margin peaked at 31.82% during Q3 2025, and registered a low of 113.77% during Q1 2021.
  • For the 5-year period, Veracyte's FCF Margin averaged around 2.01%, with its median value being 9.8% (2022).
  • Its FCF Margin has fluctuated over the past 5 years, first tumbled by -946000bps in 2021, then surged by 970600bps in 2022.
  • Veracyte's FCF Margin (Quarter) stood at 11.29% in 2021, then dropped by -13bps to 9.8% in 2022, then skyrocketed by 36bps to 13.29% in 2023, then rose by 29bps to 17.18% in 2024, then skyrocketed by 85bps to 31.82% in 2025.
  • Its FCF Margin stands at 31.82% for Q3 2025, versus 24.83% for Q2 2025 and 3.1% for Q1 2025.